Alkermes
|
Alkermes, Inc (Alkermes) is a biotechnology company. The Company manufactures RISPERDAL CONSTA for schizophrenia and developed and manufacture VIVITROL for alcohol dependence. Alkermes ia a long-acting formulation of risperidone, a product of Janssen Pharmaceutica, Inc., a division of Ortho-McNeil-Janssen Pharmaceuticals, Inc. and Janssen Pharmaceutica International, a division of Cilag International (together, Janssen). The Company has developed VIVITROL, an extended-release Medisorb formulation of naltrexone, for the treatment of alcohol dependence in patients who are able to abstain from drinking in an outpatient setting and are not actively drinking prior to treatment initiation. Its pip...
More from Zoominfo » |
FDA Approves New Injection Site For RISPERDAL
Alkermes, Inc. (NASDAQ: ALKS) today announced that patients with schizophrenia now have a new administration option for RISPERDAL® CONSTA® [(risperidone) Long-Acting Injection]. The U.S. Food and Drug Administration (FDA) has approved a new injection site, the deltoid muscle in the arm, for RISPERDAL CONSTA for the treatment of patients with schizophrenia.
From R - 19 hours ago
FDA Approves New Injection Site for RISPERDAL
Alkermes, Inc. (NASDAQ: ALKS) today announced that patients with schizophrenia now have a new administration option for RISPERDAL(R) CONSTA(R) ((risperidone) Long-Acting Injection). The U.S. Food and Drug Administration (FDA) has approved a new injection site, the deltoid muscle in the arm, for RISPERDAL CONSTA for the treatment of patients with schizophrenia. RISPERDAL CONSTA was previously ...
From R - 1 day ago
More news from Yahoo! News
|
|
|
